Undifferentiated pancreatic carcinoma
diseaseOn this page
Also known as pancreas undifferentiated carcinomapancreatic carcinosarcomapleomorphic large cell pancreatic carcinomasarcomatoid pancreatic carcinomaspindle cell pancreatic carcinomaUCPundifferentiated (anaplastic) pancreatic carcinomaundifferentiated carcinoma of pancreasundifferentiated carcinoma of the pancreas
Summary
Undifferentiated pancreatic carcinoma (MONDO:0006478) is a cancer and 1 clinical trial. Top therapeutic interventions include leucovorin. A subtype of pancreatic ductal adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | undifferentiated pancreatic carcinoma |
| Mondo ID | MONDO:0006478 |
| EFO | EFO:1000606 |
| NCIT | C5722 |
| UMLS | C1336861 |
| MedGen | 237030 |
| GARD | 0027757 |
| Anatomy (UBERON) | UBERON:0001264 |
| Is cancer (heuristic) | yes |
Also known as: pancreas undifferentiated carcinoma · pancreatic carcinosarcoma · pleomorphic large cell pancreatic carcinoma · sarcomatoid pancreatic carcinoma · spindle cell pancreatic carcinoma · UCP · undifferentiated (anaplastic) pancreatic carcinoma · undifferentiated carcinoma of pancreas · undifferentiated carcinoma of the pancreas · undifferentiated pancreatic carcinoma
Disease family
This is a subtype of pancreatic ductal adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › tubular adenocarcinoma › pancreatic ductal adenocarcinoma › undifferentiated pancreatic carcinoma
Related subtypes (4): pancreatic signet ring cell adenocarcinoma, pancreatic foamy gland adenocarcinoma, mixed ductal-endocrine carcinoma of pancreas, colloid carcinoma of the pancreas
Subtypes (1): undifferentiated pancreatic carcinoma with osteoclast-like giant cells
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02345460 | PHASE2 | TERMINATED | Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| LEUCOVORIN | 4 | 1 |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.